A Proof of Concept Study Demonstrating the Feasibility of a Text Message Prompt for Hepatitis C Testing in the 1945-1965 Birth Cohort

被引:1
|
作者
Fisk, Rebecca J. [1 ]
Kumar, Disha [2 ]
Kellogg, John B. [2 ]
Murphy, Daniel R. [3 ]
Staggers, Kristen A. [4 ]
Arya, Monisha [3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Epidemiol & Publ Hlth, Houston, TX 77030 USA
[2] Baylor Coll Med, Miscellaneous, Houston, TX 77030 USA
[3] Baylor Coll Med, Internal Med, Houston, TX 77030 USA
[4] Baylor Coll Med, Neurosurg, Houston, TX 77030 USA
关键词
hepatitis c; patient education; screening; hepatitis c virus; testing; IDENTIFICATION; INFECTION;
D O I
10.7759/cureus.4745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Despite national recommendations stating all individuals in the 1945-1965 "birth cohort" be tested for hepatitis C virus (HCV), testing rates remain low. The purpose of this proof of concept study was to assess the feasibility of text messaging to promote HCV testing among birth cohort patients. Methods Participants were assigned to receive a text message to promote HCV testing, or a general health message as a control. Participants were sent the message immediately prior to an upcoming appointment. Patients not enrolled in the study were in the standard-of-care group. To assess the impact of the text on HCV test orders on the appointment date participant charts were reviewed. Results The sample was largely non-Hispanic, Caucasian, and female. Of participants sent the HCV message (n = 22), 50.0% had a test ordered, compared to 41.7% and 27.5% in the control (n = 13) and standard-of-care groups (n = 69), respectively. Conclusion This proof of concept study demonstrated the feasibility of text messaging to promote HCV testing among birth cohort patients. Those receiving the HCV message were more likely to have an HCV test ordered compared to those who received no message, although this difference was not statistically significant. A larger study is needed to confirm these results.
引用
收藏
页数:5
相关论文
共 26 条
  • [21] Among 1945-1965 birth cohort patients with at least one additional hepatitis C virus risk factor, one in eight were positive for HCV antibody: an underserved safety-net population experience
    Hirode, G.
    Liu, B.
    Bhuket, T.
    Wong, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S316 - S316
  • [22] Awareness of Birth Cohort Hepatitis C Testing Recommendation Among Baby Boomers: An Exploratory Survey Study
    Pal, Vabhave
    Ahmed, Yasir
    Singh, Shikha
    Bhairavarasu, Kalpana
    Oud, Lavi
    SOUTHERN MEDICAL JOURNAL, 2019, 112 (03) : 147 - 153
  • [23] Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study
    Kohli, Anita
    Osinusi, Anuoluwapo
    Sims, Zayani
    Nelson, Amy
    Meissner, Eric G.
    Barrett, Lisa L.
    Bon, Dimitra
    Marti, Miriam M.
    Silk, Rachel
    Kotb, Colleen
    Gross, Chloe
    Jolley, Tim A.
    Sidharthan, Sreetha
    Petersen, Tess
    Townsend, Kerry
    Egerson, D'Andrea
    Kapoor, Rama
    Spurlin, Emily
    Sneller, Michael
    Proschan, Michael
    Herrmann, Eva
    Kwan, Richard
    Teferi, Gebeyehu
    Talwani, Rohit
    Diaz, Gabbie
    Kleiner, David E.
    Wood, Brad J.
    Chavez, Jose
    Abbott, Stephen
    Symonds, William T.
    Subramanian, G. Mani
    Pang, Phillip S.
    McHutchison, John
    Polis, Michael A.
    Fauci, Anthony S.
    Masur, Henry
    Kottilil, Shyam
    LANCET, 2015, 385 (9973): : 1107 - 1113
  • [24] Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study
    Kohli, Anita
    Kapoor, Rama
    Sims, Zayani
    Nelson, Amy
    Sidharthan, Sreetha
    Lam, Brian
    Silk, Rachel
    Kotb, Colleen
    Gross, Chloe
    Teferi, Gebeyehu
    Sugarman, Kate
    Pang, Phillip S.
    Osinusi, Anu
    Polis, Michael A.
    Rustgi, Vinod
    Masur, Henry
    Kottilil, Shyam
    LANCET INFECTIOUS DISEASES, 2015, 15 (09): : 1049 - 1054
  • [25] A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study
    Southern, William N.
    Norton, Brianna
    Steinman, Meredith
    DeLuca, Joseph
    Drainoni, Mari-Lynn
    Smith, Bryce D.
    Litwin, Alain H.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [26] A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study
    William N. Southern
    Brianna Norton
    Meredith Steinman
    Joseph DeLuca
    Mari-Lynn Drainoni
    Bryce D. Smith
    Alain H. Litwin
    BMC Infectious Diseases, 15